E-submission
Search
- Page Path
- HOME > Search
Review
- Pathology-MRI Correlation of Hepatocarcinogenesis: Recent Update
- Jimi Huh, Kyung Won Kim, Jihun Kim, Eunsil Yu
- J Pathol Transl Med. 2015;49(3):218-229. Published online May 15, 2015
- DOI: https://doi.org/10.4132/jptm.2015.04.15
- 23,974 View
- 317 Download
- 12 Web of Science
- 10 Crossref
-
Abstract
PDF - Understanding the important alterations during hepatocarcinogenesis as well as the characteristic magnetic resonance imaging (MRI) and histopathological features will be helpful for managing patients with chronic liver disease and hepatocellular carcinoma. Recent advances in MRI techniques, such as fat/iron quantification, diffusion-weighted images, and gadoxetic acid-enhanced MRI, have greatly enhanced our understanding of hepatocarcinogenesis.
-
Citations
Citations to this article as recorded by
- Update on Hepatocellular Carcinoma Imaging Features Associated With Histology, Subtype, and Prognosis Along With Changes to LI-RADS in 2024
Sergio P. Klimkowski, Ann Shi, Omar Altabbakh, Janio Szklaruk, AnuradhaS. Shenoy-Bhangle, Gauruv S. Likhari, Khaled M. Elsayes
Seminars in Roentgenology.2025; 60(1): 6. CrossRef - Gadoxetic acid in hepatocellular carcinoma and liver metastases: pearls and pitfalls
H.M. Kwok, C.M. Chau, H.C.H. Lee, T. Wong, H.F. Chan, W.H. Luk, W.T.A. Yung, L.F. Cheng, K.F.J. Ma
Clinical Radiology.2023; 78(10): 715. CrossRef - Multi-phasic magnetic resonance imaging of hemodynamic interchanges in hepatocarcinogenesis
Ahmed Mahmoud Elzeneini, Mohsen Ahmed Abdelmohsen, Mohamed Ibrahim Yousef
Egyptian Journal of Radiology and Nuclear Medicine.2023;[Epub] CrossRef - Risk Factors for Hypervascularization in Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement: A Systematic Review and Meta-analysis
Tae-Hyung Kim, Sungmin Woo, Sangwon Han, Chong Hyun Suh, Richard Kinh Gian Do, Jeong Min Lee
Academic Radiology.2022; 29(2): 198. CrossRef - Comparison of IDEAL-IQ and IVIM-DWI for Differentiating between Alpha Fetoprotein-Negative Hepatocellular Carcinoma and Focal Nodular Hyperplasia
Shaopeng Li, Peng Wang, Jun Qiu, Yiju Xie, Dawei Yin, Kexue Deng
Oncologie.2022; 24(3): 527. CrossRef - Hepatocarcinogenesis
Alice Fung, Krishna P. Shanbhogue, Myles T. Taffel, Brian T. Brinkerhoff, Neil D. Theise
Magnetic Resonance Imaging Clinics of North America.2021; 29(3): 359. CrossRef - Pathologic, Molecular, and Prognostic Radiologic Features of Hepatocellular Carcinoma
Kathryn J. Fowler, Adam Burgoyne, Tyler J. Fraum, Mojgan Hosseini, Shintaro Ichikawa, Sooah Kim, Azusa Kitao, Jeong Min Lee, Valérie Paradis, Bachir Taouli, Neil D. Theise, Valérie Vilgrain, Jin Wang, Claude B. Sirlin, Victoria Chernyak
RadioGraphics.2021; 41(6): 1611. CrossRef - Update on Hepatocellular Carcinoma: a Brief Review from Pathologist Standpoint
Nese Karadag Soylu
Journal of Gastrointestinal Cancer.2020; 51(4): 1176. CrossRef - Gadoxetate-enhanced dynamic contrast-enhanced MRI for evaluation of liver function and liver fibrosis in preclinical trials
Jimi Huh, Su Jung Ham, Young Chul Cho, Bumwoo Park, Bohyun Kim, Chul-Woong Woo, Yoonseok Choi, Dong-Cheol Woo, Kyung Won Kim
BMC Medical Imaging.2019;[Epub] CrossRef - Non-Hypervascular Hypointense Nodules at Gadoxetic Acid MRI: Hepatocellular Carcinoma Risk Assessment with Emphasis on the Role of Diffusion-Weighted Imaging
Chiara Briani, Marco Di Pietropaolo, Massimo Marignani, Francesco Carbonetti, Paola Begini, Vincenzo David, Elsa Iannicelli
Journal of Gastrointestinal Cancer.2018; 49(3): 302. CrossRef
- Update on Hepatocellular Carcinoma Imaging Features Associated With Histology, Subtype, and Prognosis Along With Changes to LI-RADS in 2024
First
Prev
